Logo image of COV.PA

COVIVIO (COV.PA) Stock Fundamental Analysis

Europe - EPA:COV - FR0000064578 - REIT

58.3 EUR
+0.55 (+0.95%)
Last: 10/20/2025, 4:16:49 PM
Fundamental Rating

3

Overall COV gets a fundamental rating of 3 out of 10. We evaluated COV against 40 industry peers in the Diversified REITs industry. COV has a medium profitability rating, but doesn't score so well on its financial health evaluation. COV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

COV had positive earnings in the past year.
COV had a positive operating cash flow in the past year.
COV had positive earnings in 4 of the past 5 years.
COV had a positive operating cash flow in each of the past 5 years.
COV.PA Yearly Net Income VS EBIT VS OCF VS FCFCOV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

The Return On Assets of COV (1.63%) is comparable to the rest of the industry.
COV has a Return On Equity of 5.08%. This is comparable to the rest of the industry: COV outperforms 52.50% of its industry peers.
With a Return On Invested Capital value of 3.21%, COV perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
COV had an Average Return On Invested Capital over the past 3 years of 2.97%. This is in line with the industry average of 3.49%.
The last Return On Invested Capital (3.21%) for COV is above the 3 year average (2.97%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.63%
ROE 5.08%
ROIC 3.21%
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
COV.PA Yearly ROA, ROE, ROICCOV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

COV has a Profit Margin of 30.46%. This is comparable to the rest of the industry: COV outperforms 47.50% of its industry peers.
In the last couple of years the Profit Margin of COV has declined.
With a Operating Margin value of 57.81%, COV is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of COV has remained more or less at the same level.
COV has a Gross Margin (74.42%) which is comparable to the rest of the industry.
COV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 57.81%
PM (TTM) 30.46%
GM 74.42%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
COV.PA Yearly Profit, Operating, Gross MarginsCOV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COV is destroying value.
COV has more shares outstanding than it did 1 year ago.
COV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for COV has been reduced compared to a year ago.
COV.PA Yearly Shares OutstandingCOV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
COV.PA Yearly Total Debt VS Total AssetsCOV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

COV has an Altman-Z score of 0.54. This is a bad value and indicates that COV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of COV (0.54) is worse than 70.00% of its industry peers.
The Debt to FCF ratio of COV is 28.44, which is on the high side as it means it would take COV, 28.44 years of fcf income to pay off all of its debts.
COV's Debt to FCF ratio of 28.44 is on the low side compared to the rest of the industry. COV is outperformed by 72.50% of its industry peers.
A Debt/Equity ratio of 1.07 is on the high side and indicates that COV has dependencies on debt financing.
COV has a Debt to Equity ratio of 1.07. This is amonst the worse of the industry: COV underperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 28.44
Altman-Z 0.54
ROIC/WACC0.55
WACC5.84%
COV.PA Yearly LT Debt VS Equity VS FCFCOV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.76 indicates that COV may have some problems paying its short term obligations.
COV has a better Current ratio (0.76) than 67.50% of its industry peers.
COV has a Quick Ratio of 0.76. This is a bad value and indicates that COV is not financially healthy enough and could expect problems in meeting its short term obligations.
COV has a Quick ratio of 0.69. This is in the better half of the industry: COV outperforms 65.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.69
COV.PA Yearly Current Assets VS Current LiabilitesCOV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

COV shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.98%.
The Earnings Per Share has been decreasing by -3.39% on average over the past years.
The Revenue has grown by 27.96% in the past year. This is a very strong growth!
COV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.17% yearly.
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%

3.2 Future

The Earnings Per Share is expected to grow by 3.36% on average over the next years.
The Revenue is expected to grow by 4.04% on average over the next years.
EPS Next Y5.08%
EPS Next 2Y3.26%
EPS Next 3Y3.36%
EPS Next 5YN/A
Revenue Next Year1.82%
Revenue Next 2Y3.23%
Revenue Next 3Y4.04%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
COV.PA Yearly Revenue VS EstimatesCOV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
COV.PA Yearly EPS VS EstimatesCOV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.65, the valuation of COV can be described as correct.
Based on the Price/Earnings ratio, COV is valued a bit cheaper than 62.50% of the companies in the same industry.
COV's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.42.
COV is valuated correctly with a Price/Forward Earnings ratio of 12.23.
62.50% of the companies in the same industry are cheaper than COV, based on the Price/Forward Earnings ratio.
COV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.94.
Industry RankSector Rank
PE 12.65
Fwd PE 12.23
COV.PA Price Earnings VS Forward Price EarningsCOV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as COV.
60.00% of the companies in the same industry are cheaper than COV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.54
EV/EBITDA 17.25
COV.PA Per share dataCOV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COV does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.49
PEG (5Y)N/A
EPS Next 2Y3.26%
EPS Next 3Y3.36%

4

5. Dividend

5.1 Amount

COV has a Yearly Dividend Yield of 6.01%, which is a nice return.
Compared to an average industry Dividend Yield of 5.84, COV pays a bit more dividend than its industry peers.
COV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 6.01%

5.2 History

The dividend of COV decreases each year by -1.54%.
Dividend Growth(5Y)-1.54%
Div Incr Years2
Div Non Decr Years2
COV.PA Yearly Dividends per shareCOV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

92.95% of the earnings are spent on dividend by COV. This is not a sustainable payout ratio.
DP92.95%
EPS Next 2Y3.26%
EPS Next 3Y3.36%
COV.PA Yearly Income VS Free CF VS DividendCOV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B
COV.PA Dividend Payout.COV.PA Dividend Payout, showing the Payout Ratio.COV.PA Dividend Payout.PayoutRetained Earnings

COVIVIO

EPA:COV (10/20/2025, 4:16:49 PM)

58.3

+0.55 (+0.95%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-21 2025-07-21/bmo
Earnings (Next)02-17 2026-02-17/amc
Inst Owners41.52%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap6.51B
Analysts81.25
Price Target64.25 (10.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.01%
Yearly Dividend0.72
Dividend Growth(5Y)-1.54%
DP92.95%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.52%
EPS NY rev (3m)-2.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.73%
Revenue NY rev (3m)2.25%
Valuation
Industry RankSector Rank
PE 12.65
Fwd PE 12.23
P/S 4.74
P/FCF 16.54
P/OCF 6.48
P/B 0.79
P/tB 0.83
EV/EBITDA 17.25
EPS(TTM)4.61
EY7.91%
EPS(NY)4.77
Fwd EY8.17%
FCF(TTM)3.52
FCFY6.04%
OCF(TTM)8.99
OCFY15.43%
SpS12.29
BVpS73.66
TBVpS70.57
PEG (NY)2.49
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.63%
ROE 5.08%
ROCE 3.59%
ROIC 3.21%
ROICexc 3.42%
ROICexgc 3.48%
OM 57.81%
PM (TTM) 30.46%
GM 74.42%
FCFM 28.68%
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
ROICexc(3y)3.08%
ROICexc(5y)2.79%
ROICexgc(3y)3.11%
ROICexgc(5y)2.81%
ROCE(3y)3.32%
ROCE(5y)3%
ROICexcg growth 3Y12.16%
ROICexcg growth 5Y0.31%
ROICexc growth 3Y11.77%
ROICexc growth 5Y0.14%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 28.44
Debt/EBITDA 9.39
Cap/Depr 417.19%
Cap/Sales 44.51%
Interest Coverage 250
Cash Conversion 106.87%
Profit Quality 94.14%
Current Ratio 0.76
Quick Ratio 0.69
Altman-Z 0.54
F-Score7
WACC5.84%
ROIC/WACC0.55
Cap/Depr(3y)709.28%
Cap/Depr(5y)708.5%
Cap/Sales(3y)50.08%
Cap/Sales(5y)56.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
EPS Next Y5.08%
EPS Next 2Y3.26%
EPS Next 3Y3.36%
EPS Next 5YN/A
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%
Revenue Next Year1.82%
Revenue Next 2Y3.23%
Revenue Next 3Y4.04%
Revenue Next 5YN/A
EBIT growth 1Y-0.73%
EBIT growth 3Y7.42%
EBIT growth 5Y0.05%
EBIT Next Year12.82%
EBIT Next 3Y8.12%
EBIT Next 5Y7.56%
FCF growth 1Y42.08%
FCF growth 3YN/A
FCF growth 5Y31.13%
OCF growth 1Y30.56%
OCF growth 3Y12.5%
OCF growth 5Y4.86%